The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Krylova L.V.

Department of Medical Rehabilitation of Patients with Central Nervous System Lesion, Hospital of War Veterans, Naberezhnye Chelny, Russia

Khasanova D.R.

Kazanskiĭ meditsinskiĭ gosudarstvennyĭ universitet

The features of botulinum therapy for different patterns of poststroke spasticity

Authors:

Krylova L.V., Khasanova D.R.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2): 42‑48

DOI: 10.17116/jnevro20171172142-48

Views: 1091

Downloaded: 34

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Krylova LV, Khasanova DR. The features of botulinum therapy for different patterns of poststroke spasticity. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2):42‑48. (In Russ.)
https://doi.org/10.17116/jnevro20171172142-48

 
МСФ на ЯМ
Close metadata
Recommended articles:
Brain-derived neurotrophic factor in the acute and early reco­very period of ischemic stroke: the role of nocturnal hypo­xemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):72-78
Immu­nological and neuroanatomic markers of the clinical dyna­mics of MCI and pre-MCI. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):81-91
Safety and effi­cacy of Rela­tox in comparison with Dysport in the treatment of focal spasticity of the upper limb in patients after stroke and traumatic brain injury (results of a prospective simple blind randomized comparative study in para­llel groups). S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):79-85
Sequential use of botu­linum toxin A and bovhyaluronidase azoximer in the correction of post-stroke spasticity. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):80-85
Five-year follow-up after neurosurgery complicated by facial neuropathy. Burdenko's Journal of Neurosurgery. 2024;(4):50-55
Capsular contracture after reco­nstructive plastic surgery for breast cancer. P.A. Herzen Journal of Onco­logy. 2024;(6):78-83
Prevention of pathological skin scars (experimental study). Plastic Surgery and Aesthetic Medi­cine. 2025;(1):32-38

Objective. To assess the efficacy of botulinum toxin therapy for different patterns of poststroke spasticity. Material and methods. Thirty-nine patients with poststroke spasticity were examined. Rehabilitation included 4 treatment courses of inpatient rehabilitation during 9 month usinga multidisciplinary team approach. Botulinum toxin therapy was included in the program. The individual program was developed taking into account the dynamics of a pathological spastic pattern. Results and conclusion. The transformation of the pathological movement pattern was observed during the rehabilitation using botulinum toxin. The best positive changes, including an improvement of the upper extremity function, walk and a decrease in the degree of paresis, was identified when botulinum toxin therapy was used in early stages of neurorehabilitation (1—3 month after stroke).

Keywords:

poststroke spasticity
botulinum toxin type A
neurorehabilitation

Authors:

Krylova L.V.

Department of Medical Rehabilitation of Patients with Central Nervous System Lesion, Hospital of War Veterans, Naberezhnye Chelny, Russia

Khasanova D.R.

Kazanskiĭ meditsinskiĭ gosudarstvennyĭ universitet

List of references:

  1. Kadykov AS, Shahparonova NV. Rehabilitation after stroke. Lechashyi vrach. 2002;01(2):1-3. (In Russ.).
  2. Dаmulin IV, Kononenko EV. Post-stroke disorders: pathogenetic and clinical aspects. Fiziologiya cheloveka. 2007;3:4-9. (In Russ.).
  3. Spasticity in adults: management using botulinum toxin. National guidelines. Royal College of Physicians. 2009;18-19.
  4. Hefter H, Jost WH, Reissing A, Zakine B, Bakheit AM, Wissel J. Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment? Int J of Rehabil Res. 2012;35(3):227-233. doi:10.1097/mrr.obo13e328353e3d4
  5. Bakheit AMO, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurology. 2001;8:559-565. doi:10.1046/j.1468-1331.2001.00277.x
  6. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009;41:13-25. doi:10.2340/16501977-0303
  7. Hatkova SE. Using botulinus toxin for treatment of patients with poststroke spasticity. Journal nevrologii I psihiatrii im S.S. Korsakova. 2009;6:87-90. (In Russ.).
  8. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity and headache. Neurology. 2016;86:1818-1826. doi:10.1212/wnl.0000000000002560
  9. Bohannon RW, Smith MBO. Inter-rater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther. 1987;67:206-207.
  10. Pandyan AD, Johnson GR, Price CIM, Curless RH, Barnes MP, Rodgers H. A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil. 1999;13:373-383. doi:10.1191/026921599677595404
  11. Ozcakir S, Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res. 2007;5:132-138. doi:10.3121/cmr.2007.716
  12. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assesment of handi-cap in stroke patients. Stroke. 1988;19:604-607. doi:10.1161/01.str.19.5.604
  13. Wallance YD. Summary of combined clinical analysis of controlled clinical trials with tizanidine. Neurology. 1994;44:60-69.
  14. Bakheit AM, Zakine B, Maisonobe P, Aymard C, Fhedoroff K, Hefter H, Jacinto J, Jost WH, Molteni F, Stam H, Turner-Stokes L, Wissel J. The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey. Int J Rehabil Res. 2010;33:199-204. doi:10. 1097/mrr.0b013e328332f5e0

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.